Risk Sharing Q&A Prove the true effectiveness of your medicines and accelerate access
Oct 15, 2014
Listen to this Q&A session with Driss Berdaï, Member of the Transparency Committee at the French HAS, Maria Kubin, Vice President of Global Market Access at Bayer, and Alexander Natz, Director General of EUCOPE, who share their advice on how to gain a complete understanding of how to implement a successful Real World Data strategy.
This content is premium content, and only accessible to Premium members. Get On Demand now